Two entry points. One to prove the value before you commit. One to govern your full network once you have.
Choose your entry point
Diagnostic Pilot
For brands that need to prove the governance gap before committing to a full rollout.
Adjustable against full rollout commitment.
Includes
Enterprise Rollout
For brands where dealer network performance is a board-level accountability item.
Per-location fee beyond 75 · Pilot fee adjustable against commitment.
Everything in Pilot, plus…
Strategic Accounts
For brands with 200+ locations · Custom terms · Founder-approved · Available post-pilot review only.
Pricing at scale
Pricing is per network — not per user, not per feature.
The accountability loop cannot be removed from any deployment. Detection without enforcement is just reporting, and reporting is not what Locus Intelligence is for.
SLA windows, hierarchy levels, and escalation thresholds are all configurable to your org structure. The escalation mechanism itself cannot be switched off.
The 0–100 accountability score methodology is standardised across all deployments. Custom scoring methodologies are not available — consistency of measurement is the governance foundation.
Pricing is not per-feature or per-user. It is structured around network scale — the number of dealer locations under governance, because that is the unit that drives operational risk and value.
→ Start here
Diagnostic Pilot
30 days · 20–40 locations · Full Risk Engine · Fee adjustable against rollout
→ Scale up
Enterprise Rollout
Monthly licence up to 75 locations · Per-location fee beyond 75 · Full network governance
→ By invitation
Strategic Accounts
200+ location brands · Custom terms · Founder-approved · Post-pilot review only
The pilot produces the internal evidence that makes a full rollout decision easy. A CMO or COO presenting a governance platform rollout to the board needs real data from their own network — not a vendor's case study. The 30-day pilot generates that evidence: real leakage data, real accountability scores, real regional variance across your locations.
The base licence covers up to 75 dealer locations with full platform access: Risk Engine, Governance, Intelligence, Microsites, Task Planner, and Locus Intelligence Chat. Beyond 75 locations a per-location monthly fee applies on top of the base. We share current figures on a pricing call, once we know your location count.
Yes. If the brand proceeds to enterprise rollout after the Day 30 pilot review, the pilot fee is credited against the first rollout invoice. The pilot is not a sunk cost — it is the first payment toward the governance deployment.
The pilot fee is not refundable, but it is fully adjustable against the first month of enterprise rollout if you proceed. The diagnostic pilot delivers real value regardless of rollout decision: a full GBP audit, health scores for 20–40 locations, a competition benchmark report, and an executive summary with quantified leakage estimates.
Pricing has two parts: a base monthly licence covering the first 75 locations, and a per-location fee for every location beyond that. A 150-location brand pays the base plus 75 locations of overage. The pilot fee is then adjustable against the first month. We walk through the exact numbers for your network on a pricing call.
Yes. Accountability tracking, the escalation loop, and the standardised health framework are non-negotiable in every deployment. SLA windows, hierarchy configuration, and escalation thresholds are fully configurable. The enforcement mechanism itself is not removable.
Strategic account terms are available for brands with 200 or more dealer locations, discussed only after the diagnostic pilot review. Strategic account pricing requires founder-level approval.
Enterprise rollout is structured as an annual commitment with monthly billing. The minimum engagement is 12 months, which reflects the time required to deploy microsites, establish health score baselines, and demonstrate measurable improvement in governance KPIs.
Enterprise pricing, strategic account terms, and rollout scope are all discussed as part of the diagnostic pilot review. Start with the pilot. Commercial discussion follows the data.